{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:29:07Z","timestamp":1787020147719,"version":"build-2736575974"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,8,13]],"date-time":"2015-08-13T00:00:00Z","timestamp":1439424000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12879-015-1089-3","type":"journal-article","created":{"date-parts":[[2015,8,12]],"date-time":"2015-08-12T10:15:10Z","timestamp":1439374510000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Effect of isoniazid preventive therapy on tuberculosis or death in persons with HIV: a retrospective cohort study"],"prefix":"10.1186","volume":"15","author":[{"given":"Henok Tadesse","family":"Ayele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike SM","family":"van Mourik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc JM","family":"Bonten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,13]]},"reference":[{"key":"1089_CR1","unstructured":"World Health Organisation. Global Tuberculosis Report 2014. Geneva; 2014. Available at: http:\/\/apps.who.int\/iris\/bitstream\/10665\/137094\/1\/9789241564809_eng.pdf?ua=1 . Accessed December 12, 2014."},{"issue":"4","key":"1089_CR2","first-page":"447","volume":"87","author":"D Wilkinson","year":"1997","unstructured":"Wilkinson D, Davies GR. The increasing burden of tuberculosis in rural South Africa--impact of the HIV epidemic. S Afr Med J. 1997;87(4):447\u201350.","journal-title":"S Afr Med J"},{"issue":"7","key":"1089_CR3","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1164\/rccm.200511-1783OC","volume":"174","author":"K Ewer","year":"2006","unstructured":"Ewer K, Millington K. a, Deeks JJ, Alvarez L, Bryant G, Lalvani A. Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med. 2006;174(7):831\u20139. doi: 10.1164\/rccm.200511-1783OC .","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"1089_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/cid\/cis798","volume":"56","author":"T Lahey","year":"2013","unstructured":"Lahey T, Mackenzie T, Arbeit RD, et al. Recurrent tuberculosis risk among HIV-infected adults in Tanzania with prior active tuberculosis. Clin Infect Dis. 2013;56(1):151\u20138. doi: 10.1093\/cid\/cis798 .","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1089_CR5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1128\/CMR.00042-10","volume":"24","author":"CK Kwan","year":"2011","unstructured":"Kwan CK, Ernst JD. HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Rev. 2011;24(2):351\u201376. doi: 10.1128\/CMR.00042-10 .","journal-title":"Clin Microbiol Rev"},{"key":"1089_CR6","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/S0140-6736(03)14333-4","volume":"362","author":"TR Frieden","year":"2003","unstructured":"Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C. Tuberculosis. Lancet. 2003;362:887\u201399. doi: 10.1016\/S0140-6736(03)14333-4 .","journal-title":"Lancet"},{"issue":"5","key":"1089_CR7","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1086\/650529","volume":"201","author":"JR Glynn","year":"2010","unstructured":"Glynn JR, Murray J, Bester A, Nelson G, Shearer S, Sonnenberg P. High rates of recurrence in HIV-infected and HIV-uninfected patients with tuberculosis. J Infect Dis. 2010;201(5):704\u201311. doi: 10.1086\/650529 .","journal-title":"J Infect Dis"},{"issue":"8","key":"1089_CR8","first-page":"942","volume":"12","author":"S Charalambous","year":"2008","unstructured":"Charalambous S, Grant AD, Moloi V, et al. Contribution of reinfection to recurrent tuberculosis in South African gold miners. Int J Tuberc Lung Dis. 2008;12(8):942\u20138.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"20","key":"1089_CR9","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1056\/NEJMsa031667","volume":"350","author":"CR Horsburgh","year":"2004","unstructured":"Horsburgh CR. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med. 2004;350(20):2060\u20137. doi: 10.1056\/NEJMsa031667 .","journal-title":"N Engl J Med"},{"key":"1089_CR10","unstructured":"Institutes N, Control D. Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents - June 18, 2008. Infection. 2008;(Cdc):1\u2013289."},{"issue":"9","key":"1089_CR11","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1164\/rccm.200603-440OC","volume":"176","author":"K DeRiemer","year":"2007","unstructured":"DeRiemer K, Kawamura LM, Hopewell PC, Daley CL. Quantitative impact of human immunodeficiency virus infection on tuberculosis dynamics. Am J Respir Crit Care Med. 2007;176(9):936\u201344. doi: 10.1164\/rccm.200603-440OC .","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"1089_CR12","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1086\/501018","volume":"42","author":"SD Lawn","year":"2006","unstructured":"Lawn SD, Bekker L-G, Middelkoop K, Myer L, Wood R. Impact of HIV Infection on the Epidemiology of Tuberculosis in a Pen-Urban Community in South Africa: The Need for Age-Specific Interventions. Clin Infect Dis. 2006;42(7):1040\u20137.","journal-title":"Clin Infect Dis"},{"key":"1089_CR13","unstructured":"Corbett EL, Watt CJ, Walker N, et al. The Growing Burden of Tuberculosis. 2014:1009\u20131021."},{"issue":"9","key":"1089_CR14","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1001\/archinte.163.9.1009","volume":"163","author":"EL Corbett","year":"2003","unstructured":"Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003;163(9):1009\u201321. doi: 10.1001\/archinte.163.9.1009 .","journal-title":"Arch Intern Med"},{"key":"1089_CR15","unstructured":"WHO\/HTM\/TB\/2004.330, WHO Stop TB. INTERIM POLICY ON COLLABORATIVE TB\/HIV ACTIVITIES.; 2004. Available at: http:\/\/apps.who.int\/iris\/handle\/10665\/78705 ."},{"key":"1089_CR16","unstructured":"UNAIDS. GLOBAL REPORT: UNAIDS report on the global AIDS epidemic 2013.; 2013. doi: JC2502\/1\/E ."},{"key":"1089_CR17","unstructured":"Gupta SS, Granich R, Suthar AB, et al. Three I\u2019s for HIV\/TB and early ART to prevent HIV and TB: Policy review of HIV and TB guidelines for high HIV\/TBburden African countries. J Int AIDS Soc. 2012;15:213. Available at: http:\/\/www.jiasociety.org\/index.php\/jias\/article\/view\/18442\/1248 ."},{"key":"1089_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000171.pub2","volume":"1","author":"S Woldehanna","year":"2004","unstructured":"Woldehanna S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev. 2004;1, CD000171. doi: 10.1002\/14651858.CD000171.pub2 .","journal-title":"Cochrane Database Syst Rev."},{"key":"1089_CR19","unstructured":"WHO. Global tuberculosis report 2013. Geneva, Switzerland; 2013."},{"key":"1089_CR20","doi-asserted-by":"publisher","unstructured":"Akolo C, Adetifa I, Shepperd S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev. 2010;(1):171. doi:Art. No.: CD000171. doi: 10.1002\/14651858.CD000171.pub3 .","DOI":"10.1002\/14651858.CD000171.pub3"},{"issue":"14","key":"1089_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0140-6736(14)60162-8","volume":"6736","author":"MX Rangaka","year":"2014","unstructured":"Rangaka MX, Wilkinson RJ, Boulle A, et al. Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial. Lancet. 2014;6736(14):1\u20139. doi: 10.1016\/S0140-6736(14)60162-8 .","journal-title":"Lancet"},{"key":"1089_CR22","unstructured":"Federal Ministry of Health. Guidelines for Implementation of the Antiretroviral Therapy Programme in Ethiopia. Fed Minist Heal Ethiop. 2007;(July)."},{"key":"1089_CR23","unstructured":"Federal Ministry of Health of Ethiopia. Implementation Guideline for TB\/HIV Collaborative Activities in Ethiopia. Addis Ababa: Federal Ministry of Health of Ethiopia: Addis Ababa; 2005."},{"key":"1089_CR24","unstructured":"Federal Ministry of Health of Ethiopia. Implementation Guideline for TB\/HIV Collaborative Activities in Ethiopia. Ethiopia: Addis Ababa; 2007."},{"issue":"1","key":"1089_CR25","doi-asserted-by":"publisher","first-page":"e1000391","DOI":"10.1371\/journal.pmed.1000391","volume":"8","author":"H Getahun","year":"2011","unstructured":"Getahun H, Kittikraisak W, Heilig CM, et al. Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: Individual participant data meta-analysis of observational studies. PLoS Med. 2011;8(1):e1000391.","journal-title":"PLoS Med"},{"key":"1089_CR26","unstructured":"World Health Organisation. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach.; 2010."},{"key":"1089_CR27","unstructured":"Rubin D. Multiple imputation for nonresponse in surveys. Wiley Classics Library; 2004."},{"key":"1089_CR28","unstructured":"Fox J, Weisberg S. Cox Proportional-Hazards Regression for Survival Data in R. The Cox Proportional-Hazards Model. 2011;(February):1\u201320."},{"key":"1089_CR29","unstructured":"IBM SPSS Amos. Statistical Package for Social Sciences. IBM Softw Bus Anal. 2012;YTD03114-U:1\u20138."},{"key":"1089_CR30","unstructured":"R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http:\/\/www.R-project.org\/ . R Found Stat Comput Vienna, Austria. 2012."},{"issue":"3","key":"1089_CR31","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10461-007-9349-x","volume":"12","author":"JA Denison","year":"2008","unstructured":"Denison JA, O\u2019Reilly KR, Schmid GP, Kennedy CE, Sweat MD. HIV voluntary counseling and testing and behavioral risk reduction in developing countries: A meta-analysis, 1990\u20132005. AIDS Behav. 2008;12(3):363\u201373.","journal-title":"AIDS Behav"},{"issue":"7","key":"1089_CR32","doi-asserted-by":"publisher","first-page":"e69437","DOI":"10.1371\/journal.pone.0069437","volume":"8","author":"C Schalkwyk Van","year":"2013","unstructured":"Van Schalkwyk C, Mndzebele S, Hlophe T, et al. Outcomes and impact of HIV prevention, ART and TB programs in Swaziland--early evidence from public health triangulation. PLoS One. 2013;8(7):e69437. doi: 10.1371\/journal.pone.0069437 .","journal-title":"PLoS One"},{"issue":"3","key":"1089_CR33","doi-asserted-by":"publisher","first-page":"336","DOI":"10.5588\/ijtld.11.0402","volume":"16","author":"T Khawcharoenporn","year":"2012","unstructured":"Khawcharoenporn T, Apisarnthanarak A, Manosuthi W, Sungkanuparph S, Mundy LM. Isoniazid preventive therapy and 4-year incidence of pulmonary tuberculosis among HIV-infected Thai patients. Int J Tuberc Lung Dis. 2012;16(3):336\u201341. doi: 10.5588\/ijtld.11.0402 .","journal-title":"Int J Tuberc Lung Dis"},{"issue":"7","key":"1089_CR34","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1473-3099(10)70078-5","volume":"10","author":"SD Lawn","year":"2010","unstructured":"Lawn SD, Wood R, De Cock KM, Kranzer K, Lewis JJ, Churchyard GJ. Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources. Lancet Infect Dis. 2010;10(7):489\u201398.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"1089_CR35","doi-asserted-by":"publisher","first-page":"a007161","DOI":"10.1101\/cshperspect.a007161","volume":"2","author":"EJ Arts","year":"2012","unstructured":"Arts EJ, Hazuda DJ. HIV-1 antiretroviral drug therapy. Cold Spring Harb Perspect Med. 2012;2(4):a007161. doi: 10.1101\/cshperspect.a007161 .","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"1089_CR36","doi-asserted-by":"publisher","first-page":"a012526","DOI":"10.1101\/cshperspect.a012526","volume":"3","author":"J Coffin","year":"2013","unstructured":"Coffin J, Swanstrom R. HIV pathogenesis: dynamics and genetics of viral populations and infected cells. Cold Spring Harb Perspect Med. 2013;3(1):a012526.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1089_CR37","unstructured":"WHO. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource- constrained settings. Department of HIV\/AIDS & Stop TB Department. Geneva, Switzerland; 2011."},{"issue":"11","key":"1089_CR38","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1097\/QAD.0b013e328216f441","volume":"21","author":"JE Golub","year":"2007","unstructured":"Golub JE, Saraceni V, Cavalcante SC, et al. The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro. Brazil AIDS. 2007;21(11):1441\u20138.","journal-title":"Brazil. AIDS."},{"issue":"5","key":"1089_CR39","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/QAD.0b013e328327964f","volume":"23","author":"JE Golub","year":"2009","unstructured":"Golub JE, Pronyk P, Mohapi L, et al. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort. AIDS. 2009;23(5):631\u20136.","journal-title":"AIDS"},{"issue":"5","key":"1089_CR40","doi-asserted-by":"publisher","first-page":"386","DOI":"10.12809\/hkmj133892","volume":"19","author":"AWC Lin","year":"2013","unstructured":"Lin AWC, Chan KCW, Chan WK, Wong KH. Tuberculin sensitivity testing and treatment of latent tuberculosis remains effective for tuberculosis control in human immunodeficiency virus-infected patients in Hong Kong. Hong Kong Med J. 2013;19(5):386\u201392. doi: 10.12809\/hkmj133892 .","journal-title":"Hong Kong Med J"},{"issue":"5","key":"1089_CR41","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1111\/j.1365-2958.2006.05467.x","volume":"62","author":"GS Timmins","year":"2006","unstructured":"Timmins GS, Deretic V. Mechanisms of action of isoniazid. Mol Microbiol. 2006;62(5):1220\u20137. doi: 10.1111\/j.1365-2958.2006.05467.x .","journal-title":"Mol Microbiol"},{"issue":"4","key":"1089_CR42","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1074\/jbc.275.4.2520","volume":"275","author":"B Lei","year":"2000","unstructured":"Lei B, Wei CJ, Tu SC. Action mechanism of antitubercular isoniazid. J Biol Chem. 2000;275(4):2520. Available at: http:\/\/www.jbc.org\/content\/275\/4\/2520.short .","journal-title":"J Biol Chem"},{"issue":"11","key":"1089_CR43","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1097\/01.aids.0000176211.08581.5a","volume":"19","author":"SD Lawn","year":"2005","unstructured":"Lawn SD, Bekker L-G, Wood R. How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control. AIDS. 2005;19(11):1113\u201324. doi: 10.1097\/01.aids.0000176211.08581.5a .","journal-title":"AIDS"},{"issue":"7","key":"1089_CR44","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1164\/rccm.200709-1311PP","volume":"177","author":"SD Lawn","year":"2008","unstructured":"Lawn SD, Wilkinson RJ, Lipman MCI, Wood R. Immune reconstitution and \u201cunmasking\u201d of tuberculosis during antiretroviral therapy. Am J Respir Crit Care Med. 2008;177(7):680\u20135. doi: 10.1164\/rccm.200709-1311PP .","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"1089_CR45","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S1473-3099(05)70140-7","volume":"5","author":"SD Lawn","year":"2005","unstructured":"Lawn SD, Bekker LG, Miller RF. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis. 2005;5(6):361\u201373. doi: 10.1016\/S1473-3099(05)70140-7 .","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"1089_CR46","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ypmed.2004.04.008","volume":"39","author":"D Guwatudde","year":"2004","unstructured":"Guwatudde D, Debanne SM, Diaz M, King C, Whalen CC. A re-examination of the potential impact of preventive therapy on the public health problem of tuberculosis in contemporary sub-Saharan Africa. Prev Med (Baltim). 2004;39(5):1036\u201346.","journal-title":"Prev Med (Baltim)"},{"issue":"9777","key":"1089_CR47","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1016\/S0140-6736(11)60204-3","volume":"377","author":"T Samandari","year":"2011","unstructured":"Samandari T, Agizew TB, Nyirenda S, et al. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial. Lancet. 2011;377(9777):1588\u201398. doi: 10.1016\/S0140-6736(11)60204-3 .","journal-title":"Lancet"},{"issue":"11","key":"1089_CR48","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1002\/sim.2712","volume":"26","author":"H Putter","year":"2007","unstructured":"Putter H, Fiocco M, Gekus RB. Tutorial in biostatistics: Competing risk and multi-state models. Stat Med. 2007;26(11):2389\u2013430.","journal-title":"Stat Med"},{"issue":"11","key":"1089_CR49","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.jclinepi.2012.04.008","volume":"65","author":"M Wolkewitz","year":"2012","unstructured":"Wolkewitz M, Allignol A, Harbarth S, De Angelis G, Schumacher M, Beyersmann J. Time-dependent study entries and exposures in cohort studies can easily be sources of different and avoidable types of bias. J Clin Epidemiol. 2012;65(11):1171\u201380.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"1089_CR50","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/aje\/kwm324","volume":"167","author":"S Suissa","year":"2008","unstructured":"Suissa S. Immortal time bias in pharmacoepidemiology. Am J Epidemiol. 2008;167(4):492\u20139. doi: 10.1093\/aje\/kwm324 .","journal-title":"Am J Epidemiol"},{"issue":"3","key":"1089_CR51","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/pds.1357","volume":"16","author":"S Suissa","year":"2007","unstructured":"Suissa S. Immortal time bias in observational studies of drug effects. Pharmacoepidemiol Drug Saf. 2007;16(3):241\u20139. doi: 10.1002\/pds.1357 .","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1089_CR52","doi-asserted-by":"publisher","first-page":"b5087","DOI":"10.1136\/bmj.b5087","volume":"340","author":"LE L\u00e9vesque","year":"2010","unstructured":"L\u00e9vesque LE, Hanley JA, Kezouh A, Suissa S. Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. BMJ. 2010;340:b5087.","journal-title":"BMJ."},{"issue":"1","key":"1089_CR53","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jclinepi.2009.03.001","volume":"63","author":"JLF Bosco","year":"2010","unstructured":"Bosco JLF, Silliman RA, Thwin SS, et al. A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies. J Clin Epidemiol. 2010;63(1):64\u201374.","journal-title":"J Clin Epidemiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-1089-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-015-1089-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-1089-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,11]],"date-time":"2016-10-11T15:53:59Z","timestamp":1476201239000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-015-1089-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,13]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1089"],"URL":"https:\/\/doi.org\/10.1186\/s12879-015-1089-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,13]]},"article-number":"334"}}